Paxil CR Trademark Details

Paxil Cr was registered on Tuesday, March 9, 2004 and is currently owned by Glaxosmithkline LLC under the registration number 2821721 . This mark is alive with a status of Registered and Renewed. The last case file activity for this mark occured 10 years ago on Tuesday, February 18, 2014, according to the United State Patent & Trademark Office
Word Mark Paxil Cr
Status Alive Registered 800 — Registered and Renewed

Current Owner

Glaxosmithkline LLC of Wilmington, DE

View all trademarks for Glaxosmithkline LLC
Other Trademarks for Glaxosmithkline LLC

Previous Owners

Smithkline Beecham Corporation of Philadelphia, PA

View all trademarks for Smithkline Beecham Corporation
Other Trademarks for Smithkline Beecham Corporation
Serial Number 78078367
Registration Number 2821721
Status Date Tuesday, February 18, 2014
Filing Date Tuesday, February 18, 2014
Registration Date Tuesday, March 9, 2004
Attorney Christopher M Hanes
Domestic Representative Christopher M Hanes

Correspondent

Christopher M Hanes
GlaxoSmithKline
LGTM, C.3157.3D
Five Moore Drive
Research Triangle Park NC 27709

Case File Statements

Indication of Colors Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text "Cr"
Goods & Services Pharmaceuticals to Treat Diseases and Disorders of the Central Nervous System

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Monday, August 13, 2001
First Use Anywhere Monday, March 4, 2002
First Use In Commerce Monday, March 4, 2002
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.